2014
DOI: 10.1038/eye.2014.237
|View full text |Cite
|
Sign up to set email alerts
|

Monitoring propranolol treatment in periocular infantile haemangioma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
3
0
2

Year Published

2016
2016
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 13 publications
0
3
0
2
Order By: Relevance
“…The studies that included other treatment modalities (e.g., Corticosteroids or surgery) are not included in the table. References (year) Number of patients and age at presentation (weeks/months) Tumor size (mm) Location Albanese et al (2019) 4 Six patients (median age of 2.7 weeks) Not available Deep ocular Ginguerra et al (2018) 15 Four patients (median age 15 weeks) 19 (median size) Deep ocular Lewitt et al (2014) 16 Five patients (median age of 5.8 weeks) Not available Deep ocular Thoumazet al (2012) 17 One patient (2 weeks) Not available Deep ocular Burne et al (2011) 18 Nine patients (6 patients with deep ocular localization) (8–50 weeks) Not available Deep ocular Li et al (2010) 19 One patient (4 weeks) 30 × 15 × 25 Deep ocular Fay et al (2010) 20 One patient (4 weeks) Not available Deep ocular Cheng et al (2010) 21 Ten patients (3 days–6 months) 756.7 (median size) Deep ocular …”
Section: Discussionmentioning
confidence: 99%
“…The studies that included other treatment modalities (e.g., Corticosteroids or surgery) are not included in the table. References (year) Number of patients and age at presentation (weeks/months) Tumor size (mm) Location Albanese et al (2019) 4 Six patients (median age of 2.7 weeks) Not available Deep ocular Ginguerra et al (2018) 15 Four patients (median age 15 weeks) 19 (median size) Deep ocular Lewitt et al (2014) 16 Five patients (median age of 5.8 weeks) Not available Deep ocular Thoumazet al (2012) 17 One patient (2 weeks) Not available Deep ocular Burne et al (2011) 18 Nine patients (6 patients with deep ocular localization) (8–50 weeks) Not available Deep ocular Li et al (2010) 19 One patient (4 weeks) 30 × 15 × 25 Deep ocular Fay et al (2010) 20 One patient (4 weeks) Not available Deep ocular Cheng et al (2010) 21 Ten patients (3 days–6 months) 756.7 (median size) Deep ocular …”
Section: Discussionmentioning
confidence: 99%
“…The impressive effect of propranolol in treating infantile hemangiomas has provoked a paradigm shift in their management over the past few years [ 18 , 19 ]. In 2008, propranolol, a nonselective β-adrenergic antagonist, was serendipitously discovered to cause regression of proliferating hemangiomas in newborns receiving treatment for cardiovascular disease [ 19 ].…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, laser treatment, embolization, or surgery may be effective for superficial hemangiomas, but remains problematic and harmful for deep or extensive forms, such as intraorbital hemangiomas. The impressive effect of propranolol in treating infantile hemangiomas has provoked a paradigm shift in their management since 2008 3,11. In addition, good tolerance of propranolol has been established 12.…”
Section: Discussionmentioning
confidence: 99%